CME Group said it reported revenue of Q4 2023 of $1.4 billion, operating income of $863 million, net income of $815 million and diluted earnings per share of $2.24. On an adjusted basis, it said net income was $865 million and diluted earnings per share was $2.37.

1. 01

   CME Group said it reported revenue of Q4 2023 of $1.4 billion, operating income of $863 million, net income of $815 million and diluted earnings per share of $2.24. On an adjusted basis, it said net income was $865 million and diluted earnings per share was $2.37.

2. 02

   The company said it recorded full-year 2023 total revenue of $5.6 billion, operating income of $3.4 billion, net income of $3.2 billion and diluted earnings per share of $8.86. Adjusted net income was $3.4 billion, and adjusted diluted earnings per share was $9.34.

3. 03

   CME Group said average daily volume (ADV) for Q4 2023 was 25.5 million contracts, up 17% from Q4 2022, and non-U.S. ADV was 7.2 million contracts, up 28%. The company's chief executive said interest rate volume in Q4 rose 36%, and Treasury futures ADV rose 46%.

4. 04

   As of December 31, 2023, the company said it held about $3.1 billion in cash (including $175 million deposited with FICC) and $3.4 billion in debt. It said it declared dividends of $3.5 billion in 2023, including the annual variable dividend of $1.9 billion. On February 8, 2024, the company declared a Q1 dividend of $1.15 per share.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.